The hypoxia-inducible factors (HIFs) play a central role in oxygen homeostasis. Hydroxylation of one or two critical prolines by specific hydroxylases (P4Hs) targets their HIF-␣ subunits for proteasomal degradation. By studying the three human HIF-P4Hs, we found that the longest and shortest isoenzymes have major transcripts encoding inactive polypeptides, which suggest novel regulation by alternative splicing. Recombinant HIFP4Hs expressed in insect cells required peptides of more than 8 residues, distinct differences being found between isoenzymes. 
droxylation, which requires oxygen, ceases under hypoxic conditions so that HIF-␣ escapes degradation and forms the ␣␤ dimer with HIF-␤. This dimer then becomes bound to the HIF-responsive elements in a number of hypoxia-inducible genes, such as those for erythropoietin, vascular endothelial growth factor, and glycolytic enzymes (for reviews, see Refs. 1 and 2).
A family of collagen prolyl 4-hydroxylases (C-P4Hs), enzymes residing within the lumen of the endoplasmic reticulum, has been extensively characterized and shown to act on -X-ProGly-sequences (7) (8) (9) . The proline residues hydroxylated in HIF-1␣ are present in -Leu-X-X-Leu-Ala-Pro-Ala-and -Leu-X-X-Leu-Ala-Pro-Tyr-sequences, however (3) (4) (5) (6) , and the human type I and type II C-P4Hs have been shown not to hydroxylate a 19-residue synthetic peptide corresponding to the sequence around Pro 564 in HIF-1␣ (4) . Three human cytoplasmic P4H isoenzymes that hydroxylate HIF-␣ (HIF-P4Hs) have since been identified (10 -12) . These novel enzymes resemble the C-P4Hs in that they require Fe 2ϩ , 2-oxoglutarate, O 2 , and ascorbate. The three HIF-P4Hs show a 42-59% sequence identity to each other but no distinct sequence similarity to the C-P4Hs. The three critical Fe 2ϩ -binding residues identified in the C-P4Hs (13, 14) are conserved, however, whereas the lysine that binds the C-5 carboxyl group of the 2-oxoglutarate (14) is replaced in the HIFP4Hs by an arginine (10, 11) . HIF-P4Hs have also been identified in Caenorhabditis elegans and Drosophila melanogaster (10, 11) .
Most experiments reported so far on the HIF-P4Hs have used enzymes prepared in reticulocyte lysates and assays based on capture of the hydroxylated substrate by the VHL protein (10 -12) . These assays do not always allow one to distinguish between the critical requirements for hydroxylation and binding of the hydroxylated product, and they are not suitable for any detailed studies of the catalytic properties of the enzymes. Preliminary data suggest that hydroxylation of Pro 402 may be less efficient than that of Pro 564 and may not be performed by HIF-P4H-3 at all (11) , but no kinetic data are available on possible differences in the hydroxylation of the two sites by the three isoenzymes, nor are any data available on possible hydroxylation of similar sequences in HIF-2␣ or HIF-3␣. It is also unknown whether the three isoenzymes show differences in their kinetic constants for O 2 and other co-substrates or for small molecule inhibitors.
In the present work we expressed all three human HIF-P4H isoenzymes as recombinant proteins in insect cells and adopted an assay based on the measurement of the amount of 14 CO 2 released during the hydroxylation-coupled decarboxylation of 2-oxo [1- 14 C]glutarate. This is similar to the assay used for the C-P4Hs (15) and made it possible to study differences between the isoenzymes in their hydroxylation of various peptide substrates and their kinetic constants for the co-substrates. We also studied inhibition of the enzymes by several compounds known to inhibit C-P4Hs. It became evident during the early stages of this work that transcripts of two of the three isoenzymes are alternatively spliced, with major variants encoding inactive polypeptides.
MATERIALS AND METHODS

Cloning of the HIF-P4H Isoenzymes and Generation of Expression
Vectors-The cDNAs encoding the human HIF-P4Hs 1-3 were obtained by PCR amplification from colon, aorta, and lung Marathon-Ready cDNAs (Clontech). The PCR products were cloned into pUC18 using the SureClone ligation kit (Amersham Biosciences) and sequenced on an automated DNA sequencer (Abi Prism 377, Applied Biosystems). Fulllength HIF-P4H-1 and -3 cDNAs were obtained, but the HIF-P4H-2 PCR product had a 51-nucleotide insertion instead of the codons for Cys 58 -Pro 175 (named HIF-P4H-2 PCR variant). The correct HIF-P4H-2 exon 1 sequence spanning this region was amplified from genomic DNA using Advantage-GC2 polymerase (BD Biosciences) and cloned as a blunt-XhoI fragment into the HIF-P4H-2 PRC variant to generate the full-length HIF-P4H-2 cDNA. The full-length HIF-P4H-1-3 cDNAs and the HIF-P4H-2 PCR variant were cloned into the pVL and pAcG3X baculovirus expression vectors (Pharmingen), and the HIF-P4H-3 cDNA was also cloned into a pBlueBacHis baculovirus expression vector (Pharmingen), and the HIF-P4H-1 and -3 cDNAs into a pMALc Escherichia coli expression vector (New England Biolabs). Site-directed mutagenesis of HIF-P4H-1 cDNA was performed using the QuikChange TM kit (Stratagene).
PCR Analysis of HIF-P4H mRNA Expression in Various Tissues-
Expression of HIF-P4H-1-3 cDNAs in various tissues was studied by PCR analysis of human multiple tissue cDNA (MTC TM ) panel I and human fetal MTC panel (Clontech) according to the manufacturer's protocol. The primer pairs 5Ј-TGCCCGGGGGATGAAGACACTGCT-GCCA-3Ј and 5Ј-TCTGCCATGCGGCTCTGGGACTGGCCAG-3Ј, and 5Ј-ATTCTGCGGGCGAGATGCCCCTGGGACA-3Ј and 5Ј-ATGAACAA-GGCCAGCAGATTTCAGAGCT-3Ј, amplifying full-length HIF-P4H-1 and HIF-P4H-3, respectively, were used in the analyses. Expression of HIF-P4H-2 mRNA was studied using the primers 5Ј-GGCCTGCGGC-CCAACGGGCAGACGAAG-3Ј (starting from nucleotide 532 of HIF-P4H-2 cDNA) and 5Ј-GGGTATTGCTGGATCAAAGGCTCTAGAAG-3Ј. The identities of the PCR products were verified by sequencing.
Expression of Recombinant HIF-P4H Isoenzymes in Insect Cells and E. coli-The recombinant baculovirus expression vectors were co-transfected into Spodoptera frugiperda Sf9 cells with BaculoGold DNA (Pharmingen) by calcium phosphate transfection, and the recombinant viruses were amplified (16) . Sf9 or High Five insect cells (Invitrogen) were cultured as monolayers in TNM-FH medium (Sigma) supplemented with 10% fetal bovine serum (BioClear) or in suspension in Sf900IISFM serum-free medium (Invitrogen). The cells were seeded at a density of 5 ϫ 10 6 /100-mm plate or 1 ϫ 10 6 /ml and infected with the recombinant viruses at a multiplicity of 5. The cells were harvested 72 h after infection, washed with a solution of 0.15 M NaCl and 0.02 M phosphate, pH 7.4, and homogenized in a 0.1 M NaCl, 0.1 M glycine, 10 M dithiothreitol, 0.1% Triton X-100, and 0.01 M Tris buffer, pH 7.8. The pellets were further solubilized in 1% SDS, and aliquots of all the soluble fractions were analyzed by 10 or 12% SDS-PAGE under reducing conditions followed by Coomassie Blue staining or Western blotting with antibodies against the histidine (Amersham Biosciences) or GST (Pharmingen) tags. The recombinant polypeptides containing histidine or GST tags were purified according to the HiTrap Chelating HP and GSTrap FF manuals (Amersham Biosciences).
The recombinant E. coli expression plasmids were transformed into the E. coli BL21(DE3) strain (Novagen). The maltose-binding protein fusion polypeptides were expressed and purified according to the pMAL protein fusion and purification system manual (New England Biolabs).
P4H Activity Assays-HIF-P4H activity was assayed by a modified method based on the hydroxylation-coupled decarboxylation of 2-oxo [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]glutarate (15) . The reaction was performed in a final volume of 1.0 ml, which contained 10 -100 l of the Triton X-100 extracts of the insect cells expressing recombinant HIF-P4H isoenzymes as sources of the enzyme, 0.025 or 0.05 mol of the peptide DLDLEMLAPYIPMD-DDFQL (Innovagen) as a substrate, 0.005 mol of FeSO 4 , 0.16 mol of 2-oxo [1- 14 C]glutarate (160 000 dpm), 2 mol of ascorbate, 60 g of catalase (Sigma), 0.1 mol of dithiothreitol, 2 mg of bovine serum albumin (Sigma), and 50 mol of Tris-HCl buffer, adjusted to pH 7.8 at 25°C. The enzyme reaction was carried out at 37°C for 20 min.
K m values for various HIF peptide substrates (Innovagen), 2-oxoglutarate, ascorbate, and O 2 were determined at saturating concentrations of the other components, except that the O 2 concentration was that of air and thus non-saturating. In the experiments in which the O 2 concentration was varied, the reaction mixtures were equilibrated by bubbling with gas mixtures of 1-45% O 2 (AGA) for 10 min at room temperature. The tubes were closed and equilibrated by shaking at room temperature for 30 min, after which the enzyme and 2-oxoglutarate were added by injection, and the tubes were incubated at 37°C. The amount of dissolved oxygen was measured with a model 781 oxygen meter equipped with a microcathode oxygen electrode (Strathkelvin Instruments). K i values were determined by adding the inhibitors at four to five constant concentrations, whereas the concentration of 2-oxoglutarate was varied.
The K m value for O 2 of purified recombinant human type I C-P4H (17) was determined using the standard P4H activity assay with (ProPro-Gly) 10 (Peptide Institute) as a substrate (15) .
RESULTS
Cloning of the HIF-P4H-1-3 cDNAs-In order to express the three human HIF-P4H isoenzymes as recombinant proteins, the cDNAs encoding human HIF-P4Hs 1-3 were amplified by PCR from human colon, aorta, and lung cDNA pools using specific primers, and the PCR products were cloned into pUC18 and sequenced (the numbers used here correspond to PHD1, PHD2, and PHD3 in Ref. 11, GenBank TM accession numbers XP_040482, AAG33965, and NP_071356, respectively). The encoded amino acid sequences of the full-length HIF-P4H-1 and HIF-P4H-3 cDNAs obtained were identical to the above GenBank TM sequences, whereas the PCR product of HIF-P4H-2 corresponded to a variant ( Fig. 1 ) in which the nucleotides encoding residues Cys 58 -Pro 175 were missing and were replaced by a 51-nucleotide stretch encoding -Leu-Leu-Gly-GlyTyr-Arg-Phe-Ala-Phe-Ser-Trp-Asn-Ser-Asp-Glu-Arg-Ala-. Surprisingly, this 51-nucleotide stretch was found to represent the non-coding strand of the HIF-P4H-2 cDNA between bp 450 -500 in a 3Ј to 5Ј direction. A slightly different HIF-P4H-2 variant lacking amino acids Gly 76 -Gly 177 has been stated previously (10) to represent a splicing variant and shown to hydroxylate Pro 564 in a HIF-1␣ peptide in vitro. Neither of these two HIF-P4H-2 PCR variants was found to follow the GT/AG consensus rule of intron splicing, however. We also attempted to amplify the HIF-P4H-2 sequence encoding amino acids Cys 58 -Pro 175 with the Advantage2 polymerase from genomic DNA but only obtained the same PCR variant as from the cDNA pools. A correct full-length PCR product could be obtained with the Advantage-GC2 polymerase, however. It is very likely that this DNA region, which has a high GC content, shows a strong tendency to form secondary structures, which makes it difficult to amplify correct products and increases the likelihood of aberrant variants.
Analysis of the Expression of mRNAs for the Three Human HIF-P4H Isoenzymes Indicates Alternative Splicing in Various
Tissues-In addition to the HIF-P4H-2 PCR variant and the full-length HIF-P4H-1 and -3 cDNAs obtained by PCR amplification of colon, aorta, and lung cDNA pools, smaller fragments originating from HIF-P4H-2 and -3 were also obtained in the same reactions. In order to analyze whether they represented alternatively spliced forms, the expression of the HIF-P4H mRNAs in various tissues was studied further by PCR amplification of adult and fetal human multiple tissue cDNA panels. For HIF-P4Hs 1 and 3 specific primers were used to amplify the full-length cDNAs, whereas in the case of HIF-P4H-2 the forward primer was from the 3Ј end of exon 1, as this exon contains a GC-rich region that easily generates PCR errors.
Full-length HIF-P4H-1 cDNA was amplified in all the tissues studied (Fig. 2A) ; no smaller PCR products were detected. The level of HIF-P4H-1 mRNA expression was highest in the adult brain, placenta, lung, and kidney ( Fig. 2A) . A full-length HIF-P4H-2 PCR product starting from the 3Ј end of exon 1, with a size of 476 bp, was likewise amplified in all the tissues (Fig.  2B) ; the levels of HIF-P4H-2 mRNA expression were the highest in the adult heart, brain, lung, and liver and in the fetal brain, heart, spleen, and skeletal muscle (Fig. 2B) . Two additional HIF-P4H-2 PCR products with smaller sizes of ϳ350 and 400 bp were obtained in amplifications from several tissues, however (Fig. 2B) , and sequencing showed that they represented splicing variants lacking the exon 3 or 4 sequences, respectively (Fig. 1) . The levels of expression of these splicing variants were considerably lower in all the tissues than that of the HIF-P4H-2 mRNA containing all the exons from 1 to 4 ( Fig.  2B ). Full-length HIF-P4H-3 cDNA was amplified from all the tissues; its expression level was the highest in the adult heart, brain, placenta, lung, and skeletal muscle and in the fetal heart, spleen, and skeletal muscle (Fig. 2C) . In addition to the band representing the full-length HIF-P4H-3 cDNA, one representing a smaller product of ϳ500 bp was found in about a 1:1 ratio in all the tissues studied ( Fig. 2C ). Sequencing of this band showed that it represented a splicing variant lacking the HIF-P4H-3 nucleotides 76 -357, and thus encoded a shortened polypeptide lacking amino acids 26 -119 ( Fig. 1 ). All the alternatively spliced HIF-P4H-2 and -3 mRNAs followed the GT/AG rule.
Recombinant Expression of the HIF-P4H Isoenzymes-The full-length HIF-P4H isoenzymes and the HIF-P4H-2 PCR variant with a -Leu-Leu-Gly-Gly-Tyr-Arg-Phe-Ala-Phe-Ser-TrpAsn-Ser-Asp-Glu-Arg-Ala-sequence replacing Cys 58 -Pro 175 were expressed as recombinant polypeptides in insect cells. All three isoenzymes were also expressed as glutathione S-transferase (GST) fusion proteins, and HIF-P4H-3 was further expressed with an N-terminal histidine tag. The cells were harvested 72 h after infection and solubilized in a buffer containing Triton X-100, and the soluble and insoluble fractions were analyzed by SDS-PAGE followed by Coomassie Blue staining. Most of the HIF-P4H-2 polypeptide was found in the soluble fraction (Fig. 3B, lane 3) , whereas the vast majority of the other polypeptides was found in the insoluble fraction ( Fig.  3 , A-C, even-numbered lanes). Nevertheless, distinct bands corresponding to isoenzyme 1 (Fig. 3A , lane 3) and the GSTfused forms of isoenzymes 1 and 3 ( Fig. 3 , A and C, lanes 5) could be seen in the soluble fraction. The HIF-P4H-2 PCR variant, GST-HIF-P4H-2 PCR variant, HIF-P4H-3 and His-HIF-P4H-3 polypeptides were not detectable in the soluble fraction in the Coomassie Blue-stained SDS-PAGE gels (Fig.  3B , lanes 5 and 7, and C, lanes 3 and 7), but a definitive level of HIF-P4H activity was found in the soluble fraction of the cells expressing these polypeptides (see below), and the presence of the histidine-tagged and GST-fused HIF-P4H-3 polypeptides in the soluble fraction could further be verified by Western blotting (Fig. 3D ).
Development of a Simple Activity Assay and Measurement of the Activities of the HIF-P4Hs in Cell Extracts-
The most commonly used assay for the C-P4Hs is based on the hydroxylation of a synthetic peptide substrate such as (Pro-Pro-Gly) 10 and measurement of the radioactivity of the 14 CO 2 formed during the hydroxylation-coupled decarboxylation of 2-oxo[1-
14 C]glutarate (15) . We adopted this assay for measurement of the activities of the HIF-P4Hs using as a standard substrate a
FIG. 1. Schematic representation of the HIF-P4H isoenzymes 1-3. The numbers of amino acids and the GenBank
TM accession numbers for the three polypeptides are shown on the right. The catalytically critical residues, two histidines and one aspartate that bind the Fe 2ϩ atom and one arginine that binds the C-5 carboxyl group of 2-oxoglutarate, are marked above the polypeptides. The amino acids lacking from the HIF-P4H-2 PCR variant are indicated by a dashed underline. The HIF-P4H-2 and -3 genes consist of four coding exons. The encoded amino acids are shown by E1-E4, and the regions subject to alternative splicing are indicated below the polypeptides.
FIG. 2. Analysis of expression of the HIF-P4H-1-3 genes and the alternatively spliced forms of HIF-P4H-2 and -3 transcripts in various tissues.
The expression of HIF-P4H-1 (A), -2 (B), and -3 (C) genes in various tissues was studied by PCR analysis of adult and fetal human multiple tissue cDNA panels. Primer pairs were designed to amplify the full-length coding sequences of HIF-P4Hs 1 and 3, whereas the 5Ј end of the HIF-P4H-2 PCR product was designed to start from nucleotide 532. In addition to the PCR products of the expected sizes, 1200, 480, and 750 bp, for HIF-P4Hs 1-3, respectively (A-C), smaller PCR products were obtained with the HIF-P4H-2 (B) and 3 (C) primers. synthetic 19-residue peptide with a sequence identical to that around the C-terminal hydroxylation site of HIF-1␣. Extensive optimization experiments resulted in the reactant concentrations and assay conditions given under "Materials and Methods." The assay was found to be linear with increasing concentrations of cell extracts expressing the recombinant enzymes for up to about 6000 -9000 dpm of 14 CO 2 generated (as shown for isoenzyme 1 in Fig. 4A ), and with time for at least 25 min provided that the amount of recombinant enzyme used produced less than about 6000 -9000 dpm in this time (as shown for isoenzyme 3 in Fig. 4B) . Variation of the concentration of the peptide substrate (as shown for isoenzyme 2 in Fig. 4C) or any of the co-substrates gave typical Michaelis-Menten kinetics (as shown for 2-oxoglutarate with respect to isoenzyme 3 in Fig.  4D ). The assay is simple and rapid and was found to be suitable for all the experiments reported below.
Significant levels of HIF-P4H activity were found in the soluble fractions of insect cells expressing any of the three recombinant isoenzymes (Table I ). The differences in the activity values shown do not represent differences in the specific activities of the three isoenzymes, as their expression levels and solubilities in the extraction buffer were not equal (see Fig.  3 ). The presence of a GST fusion partner slightly increased the activity levels obtained with HIF-P4H-1 and HIF-P4H-2 PCR variant, whereas a marked increase was obtained with HIF-P4H-3 (Table I ). These increases were most probably because of improved solubility of the GST fusion proteins in the extraction buffer (see Fig. 3 ).
The highest observed activity values for the three isoenzymes ranged to about 0.16 -0.22 nmol of 2-oxoglutarate decarboxylated per g of protein/20 min. If the purities of the isoenzymes in the cell extracts were 100%, these values would correspond to about 0.4 -0.55 mol of 2-oxoglutarate decarboxylated per mol of enzyme/min, depending on the isoenzyme. The purities of the enzymes in the soluble fractions are likely to be far less than 1%, however, and thus the true specific activities are likely to be much more than 100-fold, i.e. much more than 40 -55 mol/mol/min. Although these estimates are highly inaccurate, it should be noted that a highly purified HIF-P4H-1 produced in E. coli had a specific activity of only 12 ϫ 10 Ϫ6 mol/mol/min (18) , which agrees with our data (below), indicating that HIF-P4Hs expressed in E. coli are completely or essentially completely inactive.
Purification of the recombinant HIF-P4H isoenzymes 1 and 3 was attempted by means of GST or histidine tags, but in both cases the vast majority of the recombinant enzyme did not become bound to the affinity column or the enzyme became very loosely bound and was already eluted during the washing steps (data not shown). The HIF-P4H isoenzymes 1 and 3 were also expressed in E. coli as maltose-binding protein fusion proteins, but no enzyme activity could be detected with the purified polypeptides (data not shown). 
The Short Splicing Variants of Isoenzymes 2 and 3 Encode
Inactive Polypeptides-The HIF-P4H-2 splicing variant lacking the amino acids encoded by exon 3 is inevitably an inactive form, as it does not contain the second iron-binding histidine and the arginine that binds the C-5 carboxyl group of 2-oxoglutarate, and it was therefore not studied any further. In order to study the activity of the splicing variants of HIF-P4H-2 lacking the amino acids encoded by exon 4 and of HIF-P4H-3 lacking residues 26 -119, the corresponding cDNAs were expressed in insect cells. The cells were infected and harvested as described above, and expression of the polypeptides was analyzed by SDS-PAGE (data not shown). To verify the presence of the alternatively spliced HIF-P4H-3 polypeptide in the soluble extract, it was also expressed with an N-terminal histidine tag, and the cell extracts were analyzed by Western blotting (data not shown). No enzyme activity was detected in cell extracts expressing any of the alternatively spliced HIF-P4H-2 or -3 forms (Table I) .
The 2-Oxoglutarate-binding Arginine in HIF-P4H-1 Cannot Be Replaced by a Lysine-One distinct difference between the HIF-P4Hs and C-P4Hs is that the residue that binds the C-5 carboxyl group of the 2-oxoglutarate is an arginine in the HIF-P4Hs but a lysine in the C-P4Hs (14) . To study whether the arginine present in the HIF-P4Hs can be replaced by a lysine, we mutated Arg 367 in HIF-P4H-1 to lysine and expressed the mutant enzyme in insect cells as above. No P4H activity was found in the soluble fraction of cells expressing this mutant, indicating that arginine is an absolute requirement (Table I ). This result differs from that obtained when the 2-oxoglutarate-binding lysine in the type I C-P4H was altered to arginine, as this mutation inactivated the enzyme by 85% under standard assay conditions and increased the K m for 2-oxoglutarate about 15-fold (14) .
The HIF-P4H Isoenzymes Require Long Peptide SubstratesOur initial experiments demonstrated that none of the three HIF-P4H isoenzymes hydroxylated the peptides Leu-Ala-Pro, Leu-Ala-Pro-Tyr, Leu-Glu-Met-Leu-Ala-Pro, and Leu-Glu-MetLeu-Ala-Pro-Tyr (details not shown). We therefore decided to focus on a 19-residue peptide corresponding to the C-terminal hydroxylation site in HIF-1␣. All three isoenzymes were found to hydroxylate this peptide, with K m values of about 5-10 M (Table II) . Omission of two residues from the N terminus, resulting in a 17-residue peptide, had little effect on hydroxylation by any of the isoenzymes, whereas omission of four residues markedly increased the K m values in the cases of HIF-P4Hs 1 and 2 (Table II) . Shortening of the peptide by two additional residues, to yield a 13-residue peptide, led to increased K m values with all three isoenzymes, although the a Values are given in dpm/100 l of extractable cell protein. Similar results were obtained in more than 10 experiments. Differences in the activity values do not represent differences in the specific activities of the recombinant polypeptides, as the polypeptides differ in their solubility in the extraction buffer (see Fig. 3 ).
TABLE I HIF-P4H activity levels in Triton X-100 extracts of H5 insect cells expressing various forms of HIF-P4H isoenzymes
b P4H activity of this variant was not determined experimentally, as lack of one of the iron-binding histidines and the arginine that binds the C-5 carboxyl group of 2-oxoglutarate inevitably inactivates the polypeptide.
increase was modest in the case of HIF-P4H-3 (Table II) .
Shortening of the 19-residue peptide by two or four residues at its C terminus had only minor effects on hydroxylation by HIF-P4H-3 but marked effects in the cases of the other two isoenzymes (Table II) . Omission of one additional residue, to give a 14-residue peptide, led to a distinctly increased K m also for HIF-P4H-3, whereas omission of one or three further residues prevented hydroxylation by any of the isoenzymes (Table  II) . We also studied whether the addition of five residues to the C terminus of the 19-residue peptide, to give a 24-residue peptide, would improve interaction with the HIF-P4Hs, but we found that all the K m and V max values for this longer peptide were essentially identical to those for the 19-residue peptide (Table II) .
Shortening of the 19-residue peptide at both ends was studied with two 11-residue peptides, one of them lacking four residues in both termini and the other lacking three residues in the N terminus and five in the C terminus. The former peptide was hydroxylated by all three isoenzymes, although very ineffectively, whereas the other was hydroxylated only by isoenzymes 1 and 3 (Table II ). An 8-residue peptide lacking six residues from the N terminus and five from the C terminus was not hydroxylated by any of the isoenzymes (Table II) .
The HIF-P4H Isoenzymes Hydroxylate Pro 402 Much Less Effectively than Pro 564 , but This Difference Is Not Explained by the Difference in the Residue after the Proline-Hydroxylation of Pro
402 was studied by determining the K m and V max values for a 19-residue peptide with a sequence identical to that around the N-terminal hydroxylation site in HIF-1␣. This peptide was not hydroxylated by HIF-P4H-3 at all, and although the other two isoenzymes hydroxylated it, the K m values were more than about 20 -50 times higher than for the C-terminal peptide (Table III ).
An obvious difference between Pro 402 and Pro 564 in HIF-1␣ is that the former is present in a -Leu-Ala-Pro-Ala-sequence, whereas the latter is located in -Leu-Ala-Pro-Tyr-. We therefore studied the effects of Tyr 565 3 Ala and Tyr 565 3 Gly mutations on the 19-residue peptide corresponding to the C-terminal hydroxylation site. Only minor differences in hydroxylation were found between the wild-type peptide and the Tyr 565 3 Ala mutant, indicating that the marked differences in the hydroxylation of the N-terminal and C-terminal sites are not due to differences in the residue after the proline (Table  III) . The Tyr 565 3 Gly peptide was a slightly less good substrate for isoenzymes 2 and 3 than the Tyr 565 3 Ala mutant but still far better than the N-terminal peptide (Table III) . These results differ distinctly from those obtained in two studies using enzymes prepared in other systems and the VHL capture assay, because no capture was obtained with Tyr 565 3 Ala mutant HIF-1␣ peptides (4, 10). A third study using an unprogrammed reticulocyte lysate and the VHL capture assay nev- 
The Human HIF-P4H Isoenzymes Also Hydroxylate Peptides Related to Human HIF-2␣ and HIF-3␣ and C. elegans HIF-␣-
The K m values of the three HIF-P4H isoenzymes for a 19-residue peptide corresponding to the C-terminal hydroxylation site in HIF-2␣ were slightly to distinctly higher than those for the corresponding HIF-1␣ peptide, whereas the V max values were in two of three cases slightly lower (Table IV) . A 20-residue peptide corresponding to a potential N-terminal hydroxylation site also became hydroxylated, although it was a less good substrate than the peptide corresponding to the Cterminal site (Table IV) . Nevertheless, the difference between the two HIF-2␣ peptides was much smaller than in the case of the HIF-1␣ peptides, and all three isoenzymes acted on the N-terminal HIF-2␣ peptide (Table IV) . HIF-2␣ has an additional sequence TNIFQPLAPVAPHSPFLLD with an LAPV motif, but a corresponding peptide could not be hydroxylated by any of the HIF-P4Hs (Table IV) .
HIF-3␣ also has a sequence highly similar to that around the C-terminal hydroxylation site in HIF-1␣, and a 20-residue peptide corresponding to this sequence was found to act as a good substrate for all three HIF-P4Hs (Table IV) .
The HIF system has also been identified in C. elegans, but the human HIF-P4Hs have been reported not to act on the only hydroxylation site in the single HIF-␣ homologue of this nematode (11) . However, we obtained hydroxylation of a 20-residue peptide corresponding to the C. elegans hydroxylation site by all three human HIF-P4Hs, although with high K m values (Table IV) .
The HIF-P4H Isoenzymes Have Much Higher K m Values for O 2 than the C-P4Hs-The three HIF-P4H isoenzymes retained partial activity even in the absence of added Fe 2ϩ , suggesting that the iron atom may be more tightly bound to the HIF-P4Hs than the C-P4Hs (details not shown). It was therefore not possible to determine the K m values for Fe 2ϩ . The K m values for 2-oxoglutarate of the three HIF-P4Hs were about 3-fold and those for ascorbate about half relative to those of the type I C-P4H, and there were no significant differences in these values between the three isoenzymes (Table V) .
A striking difference between the two classes of P4H was found in the K m values for O 2 , which were determined here for both the HIF-P4Hs and the type I C-P4H in the same experiments. The K m values of the HIF-P4Hs were slightly above the concentration of dissolved O 2 in air (about 200 M), and there were no significant differences between the three isoenzymes ( Table V) . The K m of the type I C-P4H was much lower, only about one-sixth of these values (Table V) .
Several Inhibitors of C-P4Hs Also Inhibit HIF-P4Hs-Pyridine 2,4-dicarboxylate and pyridine 2,5-dicarboxylate are well established competitive inhibitors of the C-P4Hs with respect to 2-oxoglutarate, with K i values of 2 and 0.8 M, respectively (7, 8) . Pyridine 2,4-dicarboxylate was also found to be a competitive inhibitor of the HIF-P4Hs, although its K i values ranged from 7 to 40 M, depending on the isoenzyme (Table VI) . In contrast, pyridine 2,5-dicarboxylate was only a very weak inhibitor of all three isoenzymes, with K i values exceeding 300 M, which we regarded as a limit for any significant inhibition (Table VI) . Other small molecule inhibitors of C-P4Hs were also found to inhibit HIF-P4Hs, isoenzymes 2 and 3 having the lowest and isoenzyme 1 the highest K i values, but all the compounds tested were much less effective inhibitors of the HIF-P4Hs than of the C-P4Hs (Table VI) .
DISCUSSION
The activity of the human HIF system is regulated by a series of novel oxygen-dependent post-translational modifications that are mediated by specific 2-oxoglutarate dioxygenases. In normoxia, hydroxylation of at least one of two critical proline residues in the oxygen-dependent degradation domain by HIF-P4Hs (10 -12) targets HIF-␣ to capture by the VHL protein and subsequent ubiquitination and proteasomal degradation (3) (4) (5) (6) . In a complementary mechanism, hydroxylation of a conserved asparagine in the C-terminal transactivation domain by an asparaginyl hydroxylase (19 -22) prevents binding of the transcriptional co-activator p300 (21, 23) . The present data suggest still further complexity in this system, as transcripts of two of the three HIF-P4Hs, isoenzymes 2 and 3, were found to be subject to alternative splicing, with major transcripts encoding catalytically inactive polypeptides. Changes in the splicing pattern can therefore be expected to influence the amounts of the active enzymes produced.
It is well established that the C-P4Hs act more effectively on long than on short peptides, the chain length influencing the K m values, whereas the V max values for short and long peptides are essentially identical (see Ref. 8) . The minimum requirement for hydroxylation by the C-P4Hs is nevertheless fulfilled by tripeptides with the sequence X-Pro-Gly. The present data indicate that the HIF-P4Hs also require long substrates, but their minimum requirements are much longer peptides, as even one of two 11-residue peptides with a sequence corresponding to that around Pro 564 was hydroxylated by only HIFP4Hs 1 and 3, whereas the other was hydroxylated by all three isoenzymes, although very ineffectively. The data thus also indicate that the three isoenzymes are not identical with respect to their requirements for the length of their substrates. When the length requirement around Pro 564 was studied by systematically shortening a 19-residue peptide at its N-terminal or C-terminal end, all three isoenzymes hydroxylated a peptide with two residues (LA) preceding the proline, but the K m values of HIF-P4Hs 1 and 2 were very high. In the case of residues after the proline, none of the enzymes acted on a peptide with four such residues (YIPM); all three required at least five (YIPMD).
The hydroxylated peptides become bound to the VHL protein in an extended conformation, with residues 560 -567 (EM-LAOYIP, in which O is 4-Hyp) and 571-577 (DFQLRSF) forming two distinct binding sites (24, 25) . It therefore seems likely that the peptides may also become bound to the HIF-P4Hs in a similar extended conformation. The present data indicate that all three HIF-P4H isoenzymes may require at least residues 562-569 (LAPYIPMD). However, HIF-P4H-2 did not hydroxylate the 11-residue peptide LEMLAPYIPMD and none of the isoenzymes hydroxylated the 8-residue LAPYIPMD, indicating that the hypothetical minimum lengths are not sufficient when the peptides are shortened at both ends. It should further be noted that the enzymes do not strictly require these actual residues, as a recent study (26) indicates that several single residue point mutations can be tolerated with relatively minor effects in the sequence of a 16-residue peptide corresponding to amino acids 557-572 in HIF-1␣. Our data and those of Huang and co-workers (26) thus suggest that HIF-P4Hs may have a long peptide-binding site with multiple interactions.
The C-P4Hs have a peptide substrate-binding domain that is located between residues 140 and 250 in their catalytic subunits (27) and is distinct from the catalytic domain, which is located in the C-terminal regions of these polypeptides of more than 500 residues. Binding studies performed with varying techniques have shown that all the main properties of peptide binding to the enzyme tetramer are similar to those of binding to a recombinant domain. 2 No data are currently available to indicate whether the presumably long peptide-binding site of the HIF-P4Hs is also located in a separate domain or whether the peptides become directly bound to the catalytic domain, which probably has a jellyroll-like structure consisting of eight ␤-strands (11) .
It has been suggested that hydroxylation of Pro 402 in HIF-1␣ may be less effective than that of Pro 564 and may be promoted only by isoenzymes 1 and 2 (11). This suggestion was based on experiments involving hydroxylation of HIF-1␣ mutants by HIF-P4Hs produced in a reticulocyte lysate and subsequent capture of the hydroxylated polypeptides by the VHL protein. A Pro 402 3 Ala mutation was found to have only a minor effect on capture when the C-terminal site (Pro 564 ) was intact, whereas a Pro 564 3 Gly mutation with an intact N-terminal site (Pro 402 ) distinctly reduced the capture and appeared to block it in the case of isoenzyme 3, and mutation of both prolines abolished capture with all three isoenzymes (11) . Our present data explain these findings by demonstrating that the K m values of HIF-P4Hs 1 and 2 for the peptide corresponding to the Nterminal hydroxylation site were more than about 20 -50 times higher than those for the C-terminal peptide and that isoenzyme 3 did not hydroxylate the N-terminal peptide at all. It is thus likely that hydroxylation of the N-terminal site will also occur much less efficiently than that of the C-terminal site in vivo, and it even seems possible that the N-terminal site may not become hydroxylated at all in many situations. It is also evident that the patterns of hydroxylation of the two sites by the three HIF-P4Hs are not identical.
Although the HIF-2␣ sequence has up to three potential hydroxylation sites, a 19-residue peptide corresponding to one of them (TNIFQPLAPVAPHSPFLLD) could not be hydroxylated by any of the HIF-P4Hs. A HIF-2␣ peptide corresponding to the C-terminal hydroxylation site in HIF-1␣ was a good substrate for HIF-P4H-3 and a relatively good substrate for the other two isoenzymes, whereas a peptide corresponding to the N-terminal site had 2-3-fold K m values for HIF-P4Hs 1 and 2 and a much higher K m for HIF-P4H-3. The difference in the K m values of isoenzymes 1 and 2 between the two HIF-2␣ sites was thus much smaller than for HIF-1␣, and even isoenzyme 3 hydroxylated the N-terminal HIF-2␣ site. HIF-3␣ also had one site that became effectively hydroxylated by all three isoenzymes. The functions of HIF-3␣ are currently poorly understood, and an IPAS protein that functions as a dominant negative regulator of the HIF system has been shown to be one of the many splicing variants of the HIF-3␣ locus (28, 29) . Our data and those recently reported by Maynard and co-workers (29) suggest that HIF-3␣ is subject to similar regulation by proline hydroxylation as HIF-1␣ and HIF-2␣.
The K m values of the three HIF-P4Hs for O 2 were found to be essentially identical, indicating that changes in the O 2 concentration of a given cell are likely to have similar effects on the catalytic activities of all three isoenzymes. These K m values were found to be slightly above the concentration of dissolved O 2 in air and much higher than the K m for O 2 of the type I C-P4H. These data agree with the functions of the two classes of P4H, i.e. the HIF-P4Hs are effective oxygen sensors, as their K m values for O 2 are close to atmospheric oxygen concentrations and thus even small decreases in O 2 are likely to influence their activities, whereas the type I C-P4H must be able to act even in situations with low O 2 concentrations, as in wounds and tissues of low vascularity.
Stabilization of HIF-␣ polypeptides by small molecule inhibitors of HIF-P4Hs is believed to be therapeutically beneficial in diseases characterized by acute or chronic ischemia, such as myocardial infarction, stroke, peripheral vascular disease, and diabetes (10 -12) . Preliminary data indicate that several competitive inhibitors of C-P4Hs with respect to 2-oxoglutarate also inhibit HIF-P4Hs, although no K i values have been available so far (11, 12) . Our data on seven such compounds indicate that five of them inhibited all HIF-P4Hs with K i values of 50 M or lower, HIF-P4H-1 having the highest values and HIFP4Hs 2 and 3 the lowest. All the compounds were much less effective inhibitors of the HIF-P4Hs than the C-P4Hs, which is not surprising, as they were selected from those known to be effective C-P4H inhibitors (8, 30) . It should be noted, however, that the K i values of the compounds for the C-P4Hs could not be used to predict their K i values for the HIF-P4Hs. For example, pyridine 2,5-dicarboxylate, one of the most effective inhibitors of the C-P4Hs, with a K i of 0.8 M, was a particularly weak inhibitor of all three HIF-P4Hs, with K i values exceeding 300 M. Our data thus indicate that there must be distinct differences in the structures of the 2-oxogl-utarate-binding sites between the C-P4Hs and HIF-P4Hs, and even between the members of the HIF-P4H family. It thus should be possible to develop potent small molecule inhibitors for the HIF-P4Hs that show a high degree of specificity with respect to the C-P4Hs, and it might even be possible to develop inhibitors that show some specificity with respect to the individual HIF-P4Hs.
